GN Corporation is participating in Biotech Showcase 2021.
Blog
A paper on the potential of Nichi Glucan to prevent complications of coronavirus infection has been published in a journal.
It argues that Nichiglucan may prevent complications by balancing blood sugar, lipids, and blood clotting.
India’s Kasturba University team wins the 15th Fujio Cup Quiz
India’s Kasturba Medical College team won the 15th…
Obtained Japanese patent for A method of enhancement of the immune cells and blood cells
GN Corporation Co Ltd obtained a Japanese patent N…
NCRM NICHE 2020 to be held virtually
Date: October 18, 2020
All programs are delivered online
GN Corporation collaborates with Okayama University
In collaboration with Okayama University, GN conducts research on safe cell culture methods that do not use animal-derived materials.
GN Corporation collaborates with Hokkaido University
GN corporation evaluates the effect of Nichi glucan for dogs with Hokkaido University, faculty of veterinary.
Researcher John Craig Venter is awarded the 2020 Edogawa-NICHE Prize
The Edogawa NICHE Prize Committee announced awarding of the 2020 Edogawa NICHE Prize to Dr. John Craig Venter
Participation in CHINA BIO, BIO PHAMA AMERICA and BIO EUROPE
GN Corporation has been selected for JETRO’s participation support program and attends digital exhibitions.
An article on Nichi Glucan was published in Forbes Central America
The article on “Immune response to taking be…